Webinars

Anaphylaxis Update for Health Professionals

To help inform healthcare professionals, a webinar was conducted by the National Allergy Strategy in partnership with the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia on Wednesday Thursday 18 November 2021.

The expert panel included:

  • Dr Katie Frith
  • Maria Said
  • Briony Tyquin

The webinar

  • Provides information about EpiPen® and Anapen®, demonstrates use of both devices and explains what resources are available.
  • Provides information about the new ASCIA Action Plans.
  • Help you support your patients at risk of anaphylaxis.
  • The expert panel answered your questions.

Content created December 2021

Information Partner

heathdirect

COVID-19 Symptom Checker

cys heathdirect

COVID-19 Restriction Checker

cyres heathdirect 2 alogo

The National Allergy Strategy is an initiative of the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient organisations for allergy in Australia.
www.nationalallergystrategy.org.au

This project received funding from the Australian Government Department of Health.

Copyright © 2021 National Allergy Strategy